ArticleInternational journal of oncology2016

A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.

Masafumi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.